IDiyas

For the Inventor, By the Inventor

Winchester, MA, United States of America

Giulio Draetta

USPTO Granted Patents = 12 

Average Co-Inventor Count = 3.2

ph-index = 7

Forward Citations = 142(Granted Patents)


Location History:

  • Milan, IT (1998 - 2000)
  • Winchester, MA (US) (1995 - 2001)
  • Weymouth, MA (US) (2009)

Company Filing History:

goldMedal11 out of 16 
 
Mitotix, Inc.
 patents
silverMedal1 out of 13 
 
Gpc Biotech, Inc.
 patents

Years Active: 1995-2009

Loading Chart...
12 patents (USPTO):Explore Patents
1. 7566455 - E6AP-binding proteins (2009-07-28),
2. 6251585 - Assay and reagents for identifying anti-proliferative agents (2001-06-26),
3. 6068982 - Ubiquitin conjugating enzymes (2000-05-30),
4. 6015692 - CDC37 cell-cycle regulatory protein and uses related thereto (2000-01-18),
5. 5981699 - Human ubiquitin conjugating enzyme (1999-11-09),
6. 5968761 - Ubiquitin conjugating enzymes (1999-10-19),
7. 5858987 - E6AP antisense constructs and methods of use (1999-01-12),
8. 5801015 - Nucleic acid encoding a Candida cell cycle regulatory protein, TYP1 (1998-09-01),
9. 5756671 - CDC37 cell-cycle regulatory protein, and uses related thereto (1998-05-26),
10. 5744343 - Ubiquitin conjugating enzymes (1998-04-28),
11. 5691147 - CDK4 binding assay (1997-11-25),
12. 5443962 - Methods of identifying inhibitors of cdc25 phosphatase (1995-08-22),

Title: **Giulio Draetta: Innovator in Cellular Biology**

Introduction

Giulio Draetta is a distinguished inventor based in Winchester, MA, known for his significant contributions to the field of cellular biology. With a total of 12 patents to his name, Draetta has made remarkable advancements, particularly in the study of protein interactions and the development of assays for anti-proliferative agents.

Latest Patents

One of Draetta's latest inventions focuses on E6AP-binding proteins, which delve into novel protein-protein interactions in eukaryotic cells, notably in human cells. This invention highlights the role of E6AP-binding proteins in essential cellular functions such as gene expression regulation, cell-cycle control, ribosome biogenesis, and DNA repair. Notably, one of these proteins shows homology with the papillomavirus E6 protein, which also binds to E6AP.

Additionally, Draetta has developed assays and reagents for identifying anti-proliferative agents, including mitotic and meiotic inhibitors. This innovation facilitates a rapid screening test that assesses cellular proliferation in the presence of candidate agents, helping identify potential anti-mitotic or anti-meiotic activities through measuring cell-cycle checkpoints.

Career Highlights

Draetta's career features pivotal roles in companies such as Mitotix, Inc. and GPC Biotech, Inc., where he contributed his expertise in cellular biology and innovative research. His work has garnered attention for its potential applications in understanding cancer mechanisms and developing therapeutic strategies.

Collaborations

Throughout his career, Draetta has collaborated with esteemed colleagues, including Mark Rolfe and Guillaume Cottarel. These collaborations have played a significant role in expanding the scope and impact of his research in the scientific community.

Conclusion

Giulio Draetta exemplifies the spirit of innovation in the scientific domain, paving the way for advancements in cellular biology through his extensive research and development of patents. His work holds promise for future therapeutic approaches and a deeper understanding of cellular mechanisms.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…